✦ LIBER ✦

4LB Results of the Nordic randomised adjuvant trial of intermediate-dose interferon alfa-2b in high-risk melanoma

✍ Scribed by J. Hansson; S. Aamdal; L. Bastholt; M. Hernberg; B. Nilsson; U. Stierner; H. von der Maase

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Two different durations of adjuvant ther

✍ Johan Hansson; Steinar Aamdal; Lars Bastholt; Yvonne Brandberg; Micaela Hernberg 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 283 KB

Health-related quality of life in patien

✍ Y. Brandberg; S. Aamdal; L. Bastholt; M. Hernberg; U. Stierner; H. von der Maase 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 419 KB

Systemic adjuvant treatment of high-risk

✍ J.M Kirkwood 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Post-surgery adjuvant therapy with inter

✍ Alexander MM Eggermont; Stefan Suciu; Rona MacKie; Wlodzimierz Ruka; Alessandro 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 126 KB

Adjuvant therapy with pegylated interfer

✍ Alexander MM Eggermont; Stefan Suciu; Mario Santinami; Alessandro Testori; Wim H 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 236 KB

PP34. Economic analysis of adjuvant inte

✍ BE Hillner; JM Kirkwood; MB Atkins; ER Johnson; TJ Smith 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 147 KB